| Main Subject |
Hubs | Hubbers | Topics | Request |
| #1 in Business | Subscribe Email Print |
|
You are here: Home > Internet and Businesses Online > List Building > List Building-You Can't Buy Your Way Into Their Hearts |
|
Main Subject - List Building-You Can't Buy Your Way Into Their Hearts
When you're starting your journey down the list building road, you may see offers for buying a list, just buying a list of email subscribers. Wait! Don' According to USFDA, a combination product is one composed of any combination of a drug and device; biological product and device; drug and biological product t ever do that! Why? you may be saying to yourself. It's the easiest and fastest way to make money. But is it? When you buy a list of email addresses ; or drug, device, and biological product and fixed dose combination would include two or more combinations of drug. Examples of combination products may in , that's all they are--a list. The people on it don't know who you are and may not care a hoot about what it is you're selling. So, where does your mess lude drug-coated devices, drugs packaged with delivery devices in medical kits, and drugs and devices packaged separately but intended to be used together. age go? Into the recycle bin with the rest of the spam. Because that's basically what it is--spam. You haven't given the people on the list a chance t here is enormous increase in the number of combination products entering the market in the recent years. Combination products have proven advantages but fixe decide. You haven't told them that you have a newsletter about fishing. They haven't chosen to be on your list because they want more information from d dose combinations are still in the process of convincing regulatory authority on their advantages over the single ingredient formulations. Combination pro YOU. Heck, they may not even be fishing people! If they aren't, guess what's going to happen on the very first email? You got it! Unsubscribe. To mak ucts have become life saving products for the pharmaceutical companies who doesn’t have many innovative molecules in their product pipeline and have been inc e any money at all from an email list, you have to have people on it who trust you. I doubt very much that a list you buy will have anyone who knows you easingly used in the product life cycle management. Even the companies having product patents are trying to extend their product life cycle through the combi , let alone people on it who will trust you. Even worse, you may get into big trouble for spamming. If you buy this list, will you be able to prove the nation products and maximize the revenues. But the companies involved in this practice are overlooking that they are burdening the patients both economically date, time, and ISP that each member signed up from? There's also the issue of getting them into your autoresponder. Some autoresponders will take inpu and physically. They need to rightly judge the benefits of the combination products and they have to even look at the risks involved when combining the produ t lists, but others frown on importing names and addresses. If an autoresponder service does it at all, the email addresses will have to be approved by ts. Some of the combination products were well accepted by physicians while others suffered. Companies involved in development of combination products are fi the administration, and then, your list will have to opt-in again. How many of them will? Probably not many. So, OK... an autoresponder is included wit ding difficulty in defining their combination products and facing various challenges from selecting a combination to marketing it. Following aspects would a h this list, maybe. Is it worth the risk of losing your own ISP for spamming? How much money will you make from a bunch of people that don't know you f dd to the challenges in developing combination products: Which markets to tap where the combination products can do fairly well? Which combination prod om the cat up the street? I mean, really? How much money will you lose, if this is what you're going to base all your list building efforts on? Lots. cts are meaningful and rational? Which therapeutic categories to select? Which Combinations can address unmet needs of the patients? Do combin But don't get buying email lists confused with co-registration. Those are two different things. With co-registration, people at least have the benefit o tions increase the patient compliance? What would be the developing cost? How to tackle the risks encountered during combination product developmen f opting in to whatever it is you're getting them to opt in for. If you're list building with a ne t? As combination products don't fit into the traditional categories of drugs, medical devices, or biological products, the USFDA is in the process of devel wsletter, they know what it's all about. If you're list building with an ezine, they know what it's about. And here's the big thing... It's somethi ping new procedures for reviewing their safety, efficacy and quality. Professional from academic institutions, pharmaceutical industries, health care indust g they're interested in. If you want to start out right with list building, co-registration is a good alternative to doing it organically. By organic I y and representatives from various regulatory agencies are working out to design the regulatory requirements for manufacture and sale of combination products mean, putting up a squeeze page and driving traffic to it. That's probably the best way because not only are your visitors going to be highly targeted, . As there is an increasing trend of the combination products companies manufacturing such products should be able to tackle the problems involved in the de they're interested in what you have to say. Co-registration is just faster. Don't spend a lot of money on buying email lists. List building should be elopment. They need to be wiser in analyzing the market trends and the regulatory requirements. Companies that provide selfless information through particip done with the viability of the list member in mind at all times. If you aren't list building around an interested crowd, you really aren't list building tion in industry events and feedback to regulatory authorities would be able to face the challenges and will be successful in developing combination products
HTTP = HTML link (for blogs, profiles,phorums):
Related Articles:Handling Three Interview Scenarios How Your Autoresponder Email Service Will Provide a Tool for Sending Out Unlimited Follow Up Emails
|